Unknown

Dataset Information

0

Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus.


ABSTRACT: Adoptive therapies with genetically modified somatic T cells rendered HIV resistance have shown promise for AIDS therapy. A renewable source of HIV-resistant human T cells from induced pluripotent stem cells (iPSCs) would further facilitate and broaden the applicability of these therapies. Here, we report successful targeting of the CCR5 locus in iPSCs generated from T cells (T-iPSCs) or fibroblasts (fib-iPSCs) from Mauritian cynomolgus macaques (MCM), using CRISPR-Cas9 technology. We found that CCR5 editing does not affect hematopoietic and T cell differentiation potentials of fib-iPSCs. However, T-iPSCs with edited CCR5 lost their capacity to differentiate into CD4+CD8+ T cells while maintaining myeloid differentiation potential. T cells and macrophages produced from CCR5-edited MCM iPSCs did not support replication of the CCR5-tropic simian immunodeficiency viruses SIVmac239 (T cell tropic) and SIVmac316 (macrophage-tropic). Overall, these studies provide a platform for further exploration of AIDS therapies based on gene-edited iPSCs in a nonhuman primate model.

SUBMITTER: D'Souza SS 

PROVIDER: S-EPMC9023799 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Generation of SIV-resistant T cells and macrophages from nonhuman primate induced pluripotent stem cells with edited CCR5 locus.

D'Souza Saritha S SS   Kumar Akhilesh A   Weinfurter Jason J   Park Mi Ae MA   Maufort John J   Tao Lihong L   Kang HyunJun H   Dettle Samuel T ST   Golos Thaddeus T   Thomson James A JA   Reynolds Matthew R MR   Slukvin Igor I  

Stem cell reports 20220331 4


Adoptive therapies with genetically modified somatic T cells rendered HIV resistance have shown promise for AIDS therapy. A renewable source of HIV-resistant human T cells from induced pluripotent stem cells (iPSCs) would further facilitate and broaden the applicability of these therapies. Here, we report successful targeting of the CCR5 locus in iPSCs generated from T cells (T-iPSCs) or fibroblasts (fib-iPSCs) from Mauritian cynomolgus macaques (MCM), using CRISPR-Cas9 technology. We found that  ...[more]

Similar Datasets

| S-EPMC3128793 | biostudies-literature
| S-EPMC3460690 | biostudies-literature
| S-EPMC5738144 | biostudies-literature
| S-EPMC4892622 | biostudies-literature
| S-EPMC7041531 | biostudies-literature
| S-EPMC1895268 | biostudies-literature
| S-EPMC304106 | biostudies-other
| S-EPMC3633566 | biostudies-literature
| S-EPMC9107657 | biostudies-literature
| S-EPMC10415663 | biostudies-literature